Literature DB >> 11054025

Selection of human single chain Fv antibody fragments binding and inhibiting Helicobacter pylori urease.

M Houimel1, I Corthesy-Theulaz, I Fisch, C Wong, B Corthesy, J Mach, R Finnern.   

Abstract

Single chain Fv antibody fragments (scFv) binding to purified Helicobacter pylori urease were selected from a nonimmune human antibody repertoire displayed on filamentous phage. After three rounds of screening on solid phase urease, 44 clones were found to bind the enzyme and four distinct scFv were identified by sequencing their heavy and light chain variable region genes (V(H) and V(L)). Two of the selected human scFv (scFv B4 and scFv D9) inhibited the activity of H. pylori urease with inhibitory constants (K(i)) of 7 and 2 microM, respectively. Their affinity (K(d)) for H. pylori urease as determined by surface plasmon resonance ranged from 17 to 42 nM. Both scFv were able to bind to urease present on the surface of living H. pylori organisms as demonstrated by flow cytometry analysis. The binding sites of scFv B4 and D9 were mapped by the use of two random hexapeptide libraries (X6 and CX6C) displayed on filamentous bacteriophage. The selected peptide sequences were shown to inhibit scFv binding to H. pylori urease and thus could be used in a vaccination strategy as epitopes mimicking (mimotopes) the region of urease recognized by these human scFv antibody fragments. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11054025     DOI: 10.1159/000030153

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  5 in total

Review 1.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens.

Authors:  Nicole Reiche; Andreas Jung; Thomas Brabletz; Tanja Vater; Thomas Kirchner; Gerhard Faller
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Bioinformatics in molecular immunology laboratories demonstrated: Modeling an anti-CMV scFv antibody.

Authors:  Chua Kek Heng; Rofina Yasmin Othman
Journal:  Bioinformation       Date:  2006-03-27

Review 4.  Viral Related Tools against SARS-CoV-2.

Authors:  Laura Fernandez-Garcia; Olga Pacios; Mónica González-Bardanca; Lucia Blasco; Inés Bleriot; Antón Ambroa; María López; German Bou; Maria Tomás
Journal:  Viruses       Date:  2020-10-16       Impact factor: 5.048

Review 5.  Helicobacter pylori: Perturbation and restoration of gut microbiome.

Authors:  Ankita Saxena; Asish Kumar Mukhopadhyay; Shoma Paul Nandi
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.